| Verastem Inc (VSTM) | |||
|---|---|---|---|
| 1.28 0.09 (7.56%) | 08-08 16:00 | ||
| Open: | 1.17 | Pre. Close: | 1.19 |
| High: | 1.2994 | Low: | 1.16 |
| Volume: | 2,041,313 | Market Cap: | 239M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 1.3 - 1.305 | 1.305 - 1.309 |
| Low: | 1.148 - 1.153 | 1.153 - 1.158 |
| Close: | 1.271 - 1.279 | 1.279 - 1.286 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 1.52  One year: 1.77 |
| Support: | Support1: 1.15 Support2: 1.05 |
| Resistance: | Resistance1: 1.30 Resistance2: 1.52 |
| Pivot: | 1.15 |
| Moving Averages: | MA(5): 1.16 MA(20): 1.15 MA(100): 1.28  MA(250): 1.86 |
| MACD: | MACD(12,26): Signal(12,26,9): -0.01 |
| %K %D: | %K(14,3): 65.66 %D(3): 46.75 |
| RSI: | RSI(14): 62.26 |
| 52-Week: | High: 3.58 Low: 1 Change(%): -52.9 |
| Average Vol(K): | 3-Month: 1793 10-Days: 990 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VSTM ] has closed below upper band by 0.7%. Bollinger Bands are 30.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | |
| Shares Float (M) | 186.36 |
| % Held by Insiders | 137400000.00 |
| % Held by Institutions | 0.97 |
| Shares Short (K) | 8160 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -65570000.000 |
| Book Value (p.s.) | |
| Profit Margin | |
| Operating Margin | -2.00 |
| Return on Assets (ttm) | 993.1 |
| Return on Equity (ttm) | -32.5 |
| Qtrly Rev. Growth | 2200000.0 |
| Gross Profit (p.s.) | 205.325 |
| Sales Per Share | -108.312 |
| EBITDA (p.s.) | 787013.000 |
| Qtrly Earnings Growth | -0.41 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | -53.47 |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | -0.01 |
| Price to Cash Flow | 2.53 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | 4390000.000 |
